Ligand Pharmaceuticals Inc - Nov 6, 2025 SCHEDULE 13D/A Report for Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share (PTHS)

Filing Manager: LIGAND PHARMACEUTICALS INC
Reporting Manager: Ligand Pharmaceuticals Incorporated
Security: Pelthos Therapeutics Inc. Common Stock, par value $0.0001 per share
Symbol: PTHS
Shares outstanding: 10.4M shares
Disclosed Ownership: 5.19M shares
Ownership: 49.9%
Form type: SCHEDULE 13D/A
Date filed: 11/10/2025, 04:42 PM
Date of event: Nov 6, 2025
Previous filing: Jul 3, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Ligand Pharmaceuticals Incorporated	49.9%	5.19M	5.19M		/s/ Octavio Espinoza	Chief Financial Officer	0000886163